FOXO TECHNOLOGIES INC. Impairment of Intangible Assets, Finite-lived
FOXO TECHNOLOGIES INC. (FOXO) reported Impairment of Intangible Assets, Finite-lived of $1.85 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2026-04-15
- FOXO TECHNOLOGIES INC. impairment of intangible assets, finite-lived for the quarter ending 2023-12-31 was -$323.00.
- FOXO TECHNOLOGIES INC. impairment of intangible assets, finite-lived for the quarter ending 2023-09-30 was $0.00.
- FOXO TECHNOLOGIES INC. impairment of intangible assets, finite-lived for the quarter ending 2023-06-30 was $2.63M.
- FOXO TECHNOLOGIES INC. impairment of intangible assets, finite-lived for fiscal 2024 was $1.85M, a 29.79% decline from fiscal 2023.
- FOXO TECHNOLOGIES INC. impairment of intangible assets, finite-lived for fiscal 2023 was $2.63M, a 92.17% increase from fiscal 2022.
- FOXO TECHNOLOGIES INC. impairment of intangible assets, finite-lived for fiscal 2022 was $1.37M, a 242.50% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. impairment of intangible assets, finite-lived for fiscal 2021 was $400.00K.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $1.85M 10-K · filed 2026-04-15 | ||||
| 2023-12-31 | -$323.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$323.00 derived: sum of 2 quarters · filed 2025-04-15 | $2.63M derived: sum of 3 quarters · filed 2025-04-15 | $2.63M 10-K · filed 2025-04-15 | $2.63M 10-K · filed 2024-06-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $2.63M derived: sum of 2 quarters · filed 2024-11-19 | $2.63M 10-Q · filed 2024-11-19 | ||
| 2023-06-30 | $2.63M 10-Q · filed 2024-08-19 | $2.63M 10-Q · filed 2024-08-19 | |||
| 2022-12-31 | $1.37M 10-K · filed 2024-06-06 | ||||
| 2021-12-31 | $400.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |